GAL and acute respiratory distress syndrome: Notably, RJX attenuated the LPS-GalN induced ALI in a dose-dependent fashion, as evidenced by significantly less damage in the lungs of RJX-treated mice that were treated at the 2.1 and 4.2 ml/kg dose levels and were terminated healthy at 48 h.